Abstract
Purpose. To produce and characterize controlled release formulations of plasmid DNA (pDNA) loaded in poly (D,L-lactide-co-glycolide) (PLGA) microspheres both in free form and as a complex with poly (L-lysine).
Methods. Poly (L-lysine) (PLL) was used to form pDNA/PLL complexes with complexation ratio of 1:0.125 and 1:0.333 w/w to enhance the stability of pDNA during microsphere preparation and protect pDNA from nuclease attack. pDNA structure, particle size, zeta potential, drug loading, in vitro release properties, and protection from DNase I were studied.
Results. The microspheres were found to be spherical with average particle size of 3.1-3.5 μm. Drug loading of 0.6% was targeted. Incorporation efficiencies of 35.1% and 29.4-30.6% were obtained for pDNA and pDNA/PLL loaded microspheres respectively. Overall, pDNA release kinetics following the initial burst did not correlate with blank microsphere polymer degradation profile suggesting that pDNA release is convective diffusion controlled. The percentage of supercoiled pDNA in the pDNA and pDNA/PLL loaded microspheres was 16.6 % and 76.7-85.6% respectively. Unencapsulated pDNA and pDNA/PLL degraded completely within 30 minutes upon the addition of DNase I. Encapsulation of DNA/PLL in PLGA microspheres protected pDNA from enzymatic degradation.
Conclusions. The results show that using a novel process, pDNA can be stabilized and encapsulated in PLGA microspheres to protect pDNA from enzymatic degradation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
R. J. McDonald, H. D. Liggitt, L. Roche, H. T. Nguyen, R. Pearlman, O. G. Raabe, L. B. Bussey, and C. M. Gorman. Aerosol Delivery of lipid:DNA complexes to lungs of Rhesus monkeys. Pharm. Res. 15:671–678 (1998).
A. Ido, K. Nakata, Y. Kato, K. Nakao, K. Murata, M. Fujita, N. Ishii, T. Tamaoki, H. Shiku, and S. Nagataki. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promotor. Cancer Res. 55:3105–3109 (1995).
G. S. Harrison, C. J. Long, T. J. Curiel, F. Maxwell, and I. H. Maxwell. Inhibition of human immunodeficiency virus-1: Production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene. Hum. Gene Ther. 3:461–469 (1992).
J. M. Friedman, L. E. Babiss, D. F. Clayton, and J. E. Darnell. Cellular promoters incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression. Mol. Cell. Biol. 6:3791–3797 (1986).
M. Cotten and E. Wagner. Non-viral approaches to gene therapy. Curr. Opin. Biotechnol. 4:705–710 (1993).
R. I. Mahato, A. Rolland, and E. Tomlinson. Cationic lipid-based gene delivery systems: pharmaceutical perspectives. Pharm. Res. 14:853–859 (1997).
D. H. Jones, S. Corris, S. McDonald, J. C. S. Clegg, and G. H. Farrar. Poly (D,L-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine 15:814–817 (1997).
K. Kawabata, Y. Takakura, and M. Hashida. The fate of plasmid DNA after intravenous injection in mice. Involvement of scavenger receptors in its hepatic uptake. Pharm. Res. 12:825–830 (1995).
R. C. Adami, W. T. Collard, S. A. Gupta, K. Y. Kwok, J. Bonadio, and K. G. Rice. Stability of peptide-condensed plasmid DNA formulations. J. Pharm. Sci. 87:678–683 (1998).
M. Yoshida, R. I. Mahato, K. Kawabata, Y. Takakura, and M. Hashida. Disposition characteristics of plasmid DNA in the singlepass rat liver perfusion system. Pharm. Res. 13:599–603 (1996).
R. C. Mehta, R. Jeyanthi, S. Calis, B. C. Thannoo, K. W. Burton, and P. P. DeLuca. Biodegradable microspheres as depot system for parenteral delivery of peptide drugs. J. Contr. Rel. 29:375–384 (1994).
H. L. Davis, R. G. Whalen, and B. A. Demeneix. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene. Ther. 4:733–740 (1993).
R. Jeyanthi, B. C. Thanoo, R. C. Mehta, and P. P. DeLuca. Effect of solvent removal technique on the matrix characteristics of polylactide/glycolide microspsheres for peptide delivery. J. Contr. Rel. 38:235–244 (1996).
J. Hermann and R. Bodmeier. Somatostatin containing biodegradable microspheres prepared by a modified solvent evaporation method based on w/o/w-multiple emulsions. Int. J. Pharm. 126:129–138 (1995).
C. W. Pouton, P. Lucas, B. J. Thomas, A. N. Uduehi, D. A. Milray, and S. H. Moss. Polycation-DNA complex for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. J. Contr. Rel. 53:289–299 (1998).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Capan, Y., Woo, B.H., Gebrekidan, S. et al. Preparation and Characterization of Poly (D,L-Lactide-Co-Glycolide) Microspheres for Controlled Release of Poly(L-Lysine) Complexed Plasmid DNA. Pharm Res 16, 509–513 (1999). https://doi.org/10.1023/A:1018862827426
Issue Date:
DOI: https://doi.org/10.1023/A:1018862827426